Elekta AB (publ) (OTCMKTS:EKTAY) Short Interest Up 75.0% in June

Elekta AB (publ) (OTCMKTS:EKTAY) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 2,100 shares, an increase of 75.0% from the May 31st total of 1,200 shares. Based on an average trading volume of 32,800 shares, the short-interest ratio is currently 0.1 days.

Elekta AB (publ) Stock Down 0.8 %

Shares of OTCMKTS EKTAY traded down $0.05 during mid-day trading on Friday, reaching $6.15. 27,199 shares of the company traded hands, compared to its average volume of 15,892. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.76 and a current ratio of 1.00. The company’s fifty day moving average is $7.08 and its two-hundred day moving average is $7.37. Elekta AB has a fifty-two week low of $6.04 and a fifty-two week high of $8.62.

Elekta AB (publ) (OTCMKTS:EKTAY) last issued its quarterly earnings data on Wednesday, June 5th. The company reported $0.11 EPS for the quarter. The business had revenue of $475.78 million for the quarter. Elekta AB (publ) had a return on equity of 13.27% and a net margin of 7.19%. Sell-side analysts forecast that Elekta AB will post 0.42 EPS for the current fiscal year.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.